CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D006323: Heart Arrest NIH

(Synonyms: Heart Ar, Heart Arrest)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug529 NIO® (Intraosseous access) Wiki 1.00
drug772 Standard of Care (Intravenous access) Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D004630 Emergencies NIH 0.35

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Comparison of Intraosseous Versus Intravenous Access in Suspected/Confirmed COVID-19 Patient in Prehospital Setting

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

NCT04366947 Emergency Medicine Cardiopulmonary Arrest Shock Device: NIO® (Intraosseous access) Device: Standard of Care (Intravenous access)
MeSH:Heart Arrest Emergencies
HPO:Cardiac arrest Cardiorespiratory arrest

Primary Outcomes

Description: successful placement of intravascular device

Measure: Success rate of first intravascular access attempt

Time: 1 day

Secondary Outcomes

Description: time to successful access

Measure: time to successful access

Time: 1 day

Description: number of attempts to successful access

Measure: number of attempts to successful access

Time: 1 day

Description: time to therapy including but not limited to time to fluids, antibiotics, and antiarrythmics

Measure: time to infusion

Time: 1 day

Description: complication rates

Measure: complication rates

Time: 1 day

Description: the rate of survival to hospital admission

Measure: ROSC

Time: 1 day


HPO Nodes